A journal about the politics and economics of cancer: national cancer plans, drug pricing, access to care and health-system decisions. Read by policy makers, health economists and cancer-control researchers.
The Journal of Cancer Policy is published by Elsevier and catalogued by NLM from 2013 as an England-based journal appearing four times a year, indexed for MEDLINE under the subject headings Medical Oncology and Public Health. Crossref confirms Elsevier as the publisher. Elsevier describes it as an international journal, affiliated with the European Cancer Organisation, that publishes research and reviews on global cancer policy: cancer systems and services research, cancer economics and value-based care, inequalities in access and outcomes, regulatory issues for cancer drugs, radiotherapy and surgical technologies, and policy priorities for low, middle and high income countries.
Carolina Wiesner represents Instituto Nacional de Cancerología (Colombia) in the Organisation of European Cancer Institutes, which lists the centre among its members in Colombia.
Argentine diplomat leading the IAEA since 2019, whose Rays of Hope initiative expands radiotherapy and nuclear medicine access in low- and middle-income countries.
Gynaecological and breast surgeon who has directed Centre François Baclesse, the comprehensive cancer centre for Normandy in Caen, since July 2023.